- Home
- BCAT vs IART Comparison
BCAT vs IART Comparison
Compare BCAT & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAT
- IART
- Stock Information
- Founded
- BCAT 2020
- IART 1989
- Country
- BCAT United States
- IART United States
- Employees
- BCAT N/A
- IART N/A
- Industry
- BCAT Finance/Investors Services
- IART Medical/Dental Instruments
- Sector
- BCAT Finance
- IART Health Care
- Exchange
- BCAT Nasdaq
- IART Nasdaq
- Market Cap
- BCAT 1.5B
- IART 1.2B
- IPO Year
- BCAT N/A
- IART 1995
- Fundamental
- Price
- BCAT $14.54
- IART $14.16
- Analyst Decision
- BCAT
- IART Hold
- Analyst Count
- BCAT 0
- IART 6
- Target Price
- BCAT N/A
- IART $15.40
- AVG Volume (30 Days)
- BCAT 308.8K
- IART 903.3K
- Earning Date
- BCAT 01-01-0001
- IART 10-30-2025
- Dividend Yield
- BCAT 9.38%
- IART N/A
- EPS Growth
- BCAT N/A
- IART N/A
- EPS
- BCAT 1.43
- IART N/A
- Revenue
- BCAT N/A
- IART $1,621,738,000.00
- Revenue This Year
- BCAT N/A
- IART $5.74
- Revenue Next Year
- BCAT N/A
- IART $4.35
- P/E Ratio
- BCAT $11.41
- IART N/A
- Revenue Growth
- BCAT N/A
- IART 3.53
- 52 Week Low
- BCAT $13.67
- IART $11.06
- 52 Week High
- BCAT $16.38
- IART $27.13
- Technical
- Relative Strength Index (RSI)
- BCAT 43.56
- IART 43.83
- Support Level
- BCAT $14.35
- IART $15.26
- Resistance Level
- BCAT $14.70
- IART $16.42
- Average True Range (ATR)
- BCAT 0.14
- IART 0.71
- MACD
- BCAT 0.01
- IART -0.03
- Stochastic Oscillator
- BCAT 33.33
- IART 28.55
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.